Basics Pacific Biosciences of California, Inc. Pacific Biosciences of California Inc is a biotechnology company. It is engaged in design, development, and manufacture of sequencing system to help scientists resolve genetically complex problems. IPO Date: October 27, 2010 Sector: Healthcare Industry: Medical Diagnostics and Research Market Cap: $594.73M Activated in VL: True Average Daily Range Avg Daily Range: $0.25 | 3.23% Avg Daily Range (30 D): $0.06 | 4.06% Avg Daily Range (90 D): $0.06 | 4.02% Institutional Daily Volume Avg Daily Volume: 2.62M Avg Daily Volume (30 D): 7.47M Avg Daily Volume (90 D): 7.54M Trade Size Avg Trade Size (Sh.): 194 Avg Trade Size (Sh.) (30 D): 530 Avg Trade Size (Sh.) (90 D): 562 Institutional Trades Total Inst.Trades: 4,333 Avg Inst. Trade: $2.18M Avg Inst. Trade (30 D): $.74M Avg Inst. Trade (90 D): $.91M Avg Inst. Trade Volume: .23M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.39M Avg Closing Trade (30 D): $.85M Avg Closing Trade (90 D): $1.14M Avg Closing Volume: 340.52K     News Aug 6, 2025 @ 1:00 PM PacBio to Present at Upcoming Investor Conferences... Source: Pacbio Jun 21, 2025 @ 12:00 PM Long Read Sequencing Market Projected to Reach USD... Source: Sns Insider May 14, 2025 @ 8:30 AM Metagenomics Market Size, Share, Forecast & Trends... Source: Researchandmarkets.Com May 12, 2025 @ 2:56 PM PacBio Board Independent Investigation Concludes A... Source: N/A Feb 15, 2025 @ 4:09 AM PacBio Grants Equity Incentive Award to New Employ... Source: Globe Newswire Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.78 $-.14 $-1.44 Diluted EPS $-2.24 $-.14 $-1.44 Revenue $ 156.11M $ 39.77M $ 37.15M Gross Profit $ 33.38M $ 14.68M $ -1.37M Net Income / Loss $ -526.36M $ -41.93M $ -426.08M Operating Income / Loss $ -690.89M $ -44.85M $ -428.93M Cost of Revenue $ 122.74M $ 25.08M $ 38.52M Net Cash Flow $ -45.16M $ -4.09M $ 3.14M PE Ratio